Proteins with neomorphic moonlighting functions in disease

IUBMB Life

Volumn 63, Issue 7, 2011, Pages 489-494

  Jeffery, Constance J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

amyloid; dihydrolipoamide dehydrogenase; glyceraldehyde 3 phosphate dehydrogenase; isocitrate dehydrogenase; moonlighting protein; neomorphic; SMAD4; triose phosphate isomerase

Indexed keywords

AMYLOID PROTEIN; BETA 2 MICROGLOBULIN; CRYSTALLIN; DIHYDROBIOPTERIN; DIHYDROLIPOAMIDE DEHYDROGENASE; GLUCOSE 6 PHOSPHATE ISOMERASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; ISOCITRATE DEHYDROGENASE; MOONLIGHTING PROTEIN; MUTANT PROTEIN; OXIDOREDUCTASE; PROTEIN; PROTEINASE; SMAD4 PROTEIN; TRIOSEPHOSPHATE ISOMERASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYLOIDOSIS; CATALYSIS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; MUTATION; NEOMORPHIC MOONLIGHTING FUNCTION; NEOPLASM; NEUROLOGIC DISEASE; PARKINSON DISEASE; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW;

ANIMALS; DISEASE; HUMANS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; MUTATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEINS;

EID: 79959619604     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.504     Document Type: Review

References (31)

1. Copley, S. D., (2003) Enzymes with extra talents: moonlighting functions and catalytic promiscuity. Curr. Opin. Chem. Biol. 7, 265-272. (Pubitemid 36514958)
2. Jeffery, C. J., (1999) Moonlighting proteins. Trends Biochem. Sci. 24, 8-11. (Pubitemid 29074455)
3. Jeffery, C. J., (2009) Moonlighting proteins-an update. Mol. Biosyst. 5, 345-350.
4. Jeffery, C. J., (2003) Moonlighting proteins: old proteins learning new tricks. Trends Genet. 19, 415-417. (Pubitemid 36930022)
5. Jeffery C. J., (2005) Mass spectrometry and the search for moonlighting proteins. Mass Spectrom. Rev. 24, 772-782. (Pubitemid 41641697)
6. Piatigorsky, J., (1998) Multifunctional lens crystallins and corneal enzymes. More than meets the eye. Ann. N. Y. Acad. Sci. 842, 7-15.
7. Piatigorsky, J., (2003) Crystallin genes: specialization by changes in gene regulation may precede gene duplication. J. Struct. Funct. Genomics 3, 131-137. (Pubitemid 36460251)
8. Wistow, G., and, Kim, H., (1991) Lens protein expression in mammals: taxon-specificity and the recruitment of crystallins. J. Mol. Evol. 32, 262-269.
9. Graham, C., Hodin, J., and, Wistow, G. A., (1996) Retinaldehydedehydrogenase as a structural protein in a mammalian eye lens. Gene recruitment of eta-crystallin. J. Biol. Chem. 271, 15623-15628. (Pubitemid 26225337)
10. Chaput, M., Claes, V., Portetelle, D., Cludts, I., Cravador, A., et al. (1988) The neurotrophic factor neuroleukin is 90% homologous with phosphohexose isomerase. Nature 332, 454-455. (Pubitemid 18090248)
11. Faik, P., Walker, J. I., Redmill, A. A., and, Morgan, M. J., (1988) Mouse glucose-6-phosphate isomerase and neuroleukin have identical 3' sequences. Nature 332, 455-457.
12. Gurney, M. E., Apatoff, B. R., Spear, G. T., Baumel, M. J., Antel, J. P., et al. (1986) Neuroleukin: a lymphokine product of lectin-stimulated T cells. Science 234, 574-581. (Pubitemid 17186170)
13. Gurney, M. E., Heinrich, S. P., Lee, M. R., and, Yin, H.-S., (1986) Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons. Science 234, 566-574. (Pubitemid 17186169)
14. Watanabe, H., Takehana, K., Date, M., Shinozaki, T., and, Raz, A., (1996) Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide. Cancer Res. 56, 2960-2963. (Pubitemid 26199739)
15. Xu, W., Seiter, K., Feldman, E., Ahmed, T., and, Chiao, J. W., (1996) The differentiation and maturation mediator for human myeloid leukemia cells shares homology with neuroleukin or phosphoglucose isomerase. Blood 87, 4502-4506. (Pubitemid 26162355)
16. Barker, D. F., and, Campbell, A. M., (1981) Genetic and biochemical characterization of the birA gene and its product: evidence for a direct role of biotin holoenzyme synthetase in repression of the biotin operon in Escherichia coli. J. Mol. Biol. 146, 469-492. (Pubitemid 11100438)
17. Edgell, D. R., Derbyshire, V., Van Roey, P., LaBonne, S., Stanger, M. J., Li, Z., et al. (2004) Intron-encoded homing endonuclease I-TevI also functions as a transcriptional autorepressor. Nat. Struct. Mol. Biol. 11, 936-944. (Pubitemid 39315296)
18. Van Roey, P., Waddling, C. A., Fox, K. M., Belfort, M., and, Derbyshire, V., (2001) Intertwined structure of the DNA-binding domain of intron endonuclease I-TevI with its substrate. EMBO J. 20, 3631-3637. (Pubitemid 32691774)
19. Citron, B. A., Davis, M. D., Milstien S., Gutierrez, J., Mendel, D. B., et al. (1992) Identity of 4a-carbinolamine dehydrtase, a component of the phenylalanine hydroxylation system, and DCoH, a transregulator of homeodomain proteins. Proc. Natl. Acad. Sci. USA 89, 11891-11894. (Pubitemid 23004750)
20. Gierasch L. M., (2011) How one bad protein spoils the barrel: structural details of β(2)-microglobulin amyloidogenicity. Mol. Cell. 41, 129-131.
21. Liz, M. A., Mar, F. M., Franquinho, F., and, Sousa, M. M., (2010) Aboard transthyretin: from transport to cleavage. IUBMB Life 62, 429-435.
22. Sekijima, Y., Kelly, J. W., and, Ikeda, S., (2008) Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses. Curr. Pharm. Des. 14, 3219-3230.
23. Mazzola J. L., and, Sirover M. A., (2002) Alteration of nuclear glyceraldehyde-3-phosphate dehydrogenase structure in Huntington's disease fibroblasts. Brain Res. Mol. Brain Res. 100, 95-101. (Pubitemid 34465582)
24. Mazzola, J. L., and, Sirover, M. A., (2002) Alteration of intracellular structure and function of glyceraldehyde-3-phosphate dehydrogenase: a common phenotype of neurodegenerative disorders? Neurotoxicology 23, 603-609. (Pubitemid 36527680)
25. Olzscha, H., Schermann, S. M., Woerner, A. C., Pinkert, S., Hecht, M. H., et al. (2011) Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions. Cell 144, 67-78.
26. Orosz, F., Oláh, J., and, Ovádi, J., (2006) Triosephosphate isomerase deficiency: facts and doubts. IUBMB Life 58, 703-715. (Pubitemid 46895567)
27. Takaesu, N. T., Herbig, E., Zhitomersky, D., O'Connor, M. B., and, Newfeld, S. J., (2005) DNA-binding domain mutations in SMAD genes yield dominant-negative proteins or a neomorphic protein that can activate WG target genes in Drosophila. Development 132, 4883-4894. (Pubitemid 41685296)
28. Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., et al. (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739-744.
29. Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., etal. (2010) The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting α-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17, 225-234.
30. Babady, N. E., Pang, Y. P., Elpeleg, O., and, Isaya, G., (2007) Cryptic proteolytic activity of dihydrolipoamidedehydrogenase. Proc. Natl. Acad. Sci. USA 104, 6158-6163.
31. Brautigam, C. A., Chuang, J. L., Tomchick, D. R., Machius, M., and, Chuang, D. T., (2005) Crystal structure of human dihydrolipoamide dehydrogenase: NAD+/NADH binding and the structural basis of disease-causing mutations. J. Mol. Biol. 350, 543-552. (Pubitemid 40828913)